ICI Europe is not just another broad immuno-oncology meeting. It focuses specifically on the preclinical, translational and clinical challenges that drug developers face in advancing more checkpoint inhibitors onto the market.
Combining data driven case studies with interactive experience sharing sessions, this year’s program will provide cutting edge insights into novel checkpoint pathways, more predictive preclinical models, the optimal combination strategies, patient stratification biomarkers and emerging clinical trial data.
Join the leaders of the immuno-oncology community in Munich to seize on the wealth of opportunities. ICI Europe will ensure that you:
Enhance the synergy of immuno-oncology combinations
Learn from BMS and Genentech’s combination approaches, allowing you to improve patient outcomes while maintaining tolerability. Gain additional insights into the scheduling, dosing and timing of a variety of combinations, allowing you to analyse the rationale behind your combination approach.
Identify robust, clinically relevant biomarkers
Target resources more effectively by investigating clinically relevant biomarkers to identify responding populations. Investigate the avelumab companion diagnostic program with EMD Serono and understand how MSD have refined their biomarker strategy in the era or combinations.
Discover the true potential of the next generation immune checkpoint pathways
Understand how Novartis, Ablynx and Effimune enhance immune responses by targeting novel checkpoint pathways, including IDO1, SIRPα, LAG-3 and TIM-3. Broaden the efficacy of immunotherapy by learning how Innate Pharma target NK cell immune checkpoints to harness the innate and adaptive immune responses.
Attend the 2nd Annual Immune Checkpoint Inhibitors Europe summit to gain the tools you need to realise the potential of your immune checkpoint inhibitor programs.
Gold: Conference and 2 workshops: EUR 3497
Silver: Conference and 1 workshop: EUR 2998
Bronze: Conference only: EUR 2499
Workshops - individual: EUR 599
Speakers: Roger Dansey, Marlon Hinner, Bernard Vanhove, Jun Wang, Alan Wise, Nicolai Wagtmann, Udo Gaipl, Arnold Gelb, Tanja de Gruijl, Niina Veitonmäki, Helen Angell, Bastian Schilling, Sukhvinder Sidhu, Catherine Sabatos-Peyton, Rosalie Luiten, Sabine Maier, Markus Mohrs, Tom Lillie, Zahra Jawad, Sandra Li, Jessie English, Gary Bembridge, Markus Hecht
Sign in to add slides, notes or videos to this session